Latest Therapeutic hypothermia Stories
Life Recovery Systems has announced that its ThermoSuit system, a rapid patient cooling device, has been approved by the FDA for use in a clinical study of patients with traumatic brain injury. Currently, the ThermoSuit system is used to induce rapid cooling of victims of cardiac arrest and heart attacks. The study is being conducted under an investigational device exemption by Guy Clifton and other researchers at the University of Texas Health Science Center in Houston, whose institutional...
WALDWICK, N.J., Sept. 9 /PRNewswire/ -- Life Recovery Systems' ThermoSuit(R) System, a rapid patient cooling device, has been approved by the U.S. Food and Drug Administration for use in a clinical study of patients with traumatic brain injury. Currently, the ThermoSuit System is used to induce rapid cooling of victims of cardiac arrest and heart attacks. The study is being conducted under an Investigational Device Exemption by Dr. Guy Clifton and other researchers at the University of...
SAN DIEGO, July 14 /PRNewswire-FirstCall/ -- Cardium Therapeutics and its operating unit InnerCool Therapies, Inc., announced today that InnerCool's RapidBlue(TM) endovascular temperature modulation system conforms to the European Union CE Mark requirements for use in inducing, maintaining and reversing mild hypothermia in a variety of clinical indications including cardiac arrest, neurosurgery, fever, cardiovascular re-warming, trauma re-warming, and potential additional applications...
SAN DIEGO, June 19 /PRNewswire-FirstCall/ -- Cardium Therapeutics and its operating unit InnerCool Therapies announced today that InnerCool has entered into a exclusive commercialization agreement with N.G.C. Medical S.p.A., a leading Italian distributor of medical products. N.G.C. Medical primarily sells medical products to the intensive care, surgical and interventional cardiology markets. They also provide in-service management of surgical suites, intensive care units and interventional...
Two months after a clogged artery stopped his heart, Tom Fuller plucks his bass guitar just a tiny bit more slowly than he used to. His handwriting is a little sloppier. After that, Fuller runs out of his list of things he can't do quite as well as he did before April 13, when he collapsed in his Sacramento driveway. While no one can be certain, his cardiologist thinks it's "very possible" that Fuller's recovery was aided by the new cold wave gradually taking hold in emergency care....
Second of two parts Her skin cold to the touch, Anna Kindt lay in the hospital as frigid saline was pumped into her veins for more than 10 days. A crack about one-third of an inch wide ran along the top and right side of Kindt's skull, just one of several fractures to her head and face. Her car looked just as bad, a collapsed roof and a crushed side. While passing another car on the shoulder of a road near Hartland in August 2006, Kindt lost control of her Honda Civic, which turned into a...
IRVINE, Calif., Jan. 24 /PRNewswire-FirstCall/ -- Alsius Corporation , the worldwide leader in intravascular temperature management therapies, today launched the Thermogard XP(TM) Intravascular Temperature Management system designed to provide an enhanced level of therapeutic cooling power to clinicians serving critically ill and surgical patients that require central venous access. Alsius' Intravascular Temperature Management (IVTM(TM)) systems provide cooling and warming therapy via a...
Cardium Therapeutics (OTCBB:CDTP) and its operating unit, InnerCool Therapies, today announced that temperature modulation therapy in cardiac arrest patients was featured in Newsweek's July 23 cover story. The article, "This Man Was Dead. He Isn't Anymore" (http://www.msnbc.msn.com/id/19751440/site/newsweek/), examines how physicians at the University of Pennsylvania are using mild hypothermia to treat sudden cardiac arrest patients. Patient temperature modulation is a...
Cardium Therapeutics (OTCBB:CDTP) and its subsidiary InnerCool Therapies announced today the enrollment of the first patient in the RAPID MI-ICE study at Lund University Hospital in Sweden. The purpose of the study is to assess the safety and potential medical utility of early and rapid cooling of patients with myocardial infarction (MI or heart attack). Previous clinical data suggest early and rapid cooling with InnerCool's endovascular catheter-based temperature modulation system...
Cardium Therapeutics (OTCBB:CDTP) and its subsidiary InnerCool Therapies announced today that its endovascular temperature modulation technology was featured in the March 2007 issue of Men's Health. The article "The Miracle on Ice" highlights the benefits of InnerCool's Celsius Control System during a cranial bypass surgery performed at Stanford University Medical Center. A copy of the article can be accessed at http://www.nxtbook.com/nxtbooks/rms/menh_1-19934755/. A reporter for Men's...
